Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
22.02
+0.23 (1.03%)
Nov 21, 2024, 3:14 PM EST - Market open
Fresenius Medical Care AG Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for FMS stock has a target of 23, which predicts an increase of 4.47% from the current stock price of 22.02.
Analyst Consensus: Hold
* Price targets were last updated on Oct 7, 2024.
Analyst Ratings
The average analyst rating for FMS stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | +4.47% | Oct 7, 2024 |
Truist Securities | Truist Securities | Hold Maintains $24 → $22 | Hold | Maintains | $24 → $22 | -0.07% | Jul 31, 2024 |
Truist Securities | Truist Securities | Hold Maintains $21 → $24 | Hold | Maintains | $21 → $24 | +9.02% | May 15, 2024 |
HSBC | HSBC | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Nov 24, 2023 |
Truist Securities | Truist Securities | Hold Maintains $28 → $24 | Hold | Maintains | $28 → $24 | +9.02% | Oct 11, 2023 |
Financial Forecast
Revenue This Year
19.50B
from 19.45B
Increased by 0.24%
Revenue Next Year
20.17B
from 19.50B
Increased by 3.41%
EPS This Year
2.79
from 1.70
Increased by 64.23%
EPS Next Year
3.43
from 2.79
Increased by 22.72%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 20.6B | 21.4B | 22.4B | ||
Avg | 19.5B | 20.2B | 20.9B | ||
Low | 18.6B | 19.0B | 19.5B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 5.9% | 9.9% | 11.2% | ||
Avg | 0.2% | 3.4% | 3.6% | ||
Low | -4.4% | -2.7% | -3.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 3.39 | 4.45 | 5.33 | ||
Avg | 2.79 | 3.43 | 3.86 | ||
Low | 1.48 | 1.97 | 2.19 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 99.5% | 59.5% | 55.7% | ||
Avg | 64.2% | 22.7% | 12.8% | ||
Low | -13.0% | -29.4% | -36.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.